SHINE Technologies has announced the launch of Ilumira, their first branded medical isotope product. This milestone represents over 10 years of hard work and innovation from their talented team.
Ilumira, their n.c.a. lutetium-177, is a revolutionary radioisotope. When paired with a cancer-seeking molecule, it precisely targets tumors and metastases and delivers a powerful dose of radiation to kill cancer cells while minimizing harm to healthy tissue.
Ilumira can transform cancer care by:
- Illuminating and treating cancer as part of a powerful theranostic technique
- Addressing critical supply chain challenges in the medical isotope industry
- Setting a new standard in production and shipping
